JPH0663131A - Method for selectively removing leucocyte - Google Patents

Method for selectively removing leucocyte

Info

Publication number
JPH0663131A
JPH0663131A JP3135364A JP13536491A JPH0663131A JP H0663131 A JPH0663131 A JP H0663131A JP 3135364 A JP3135364 A JP 3135364A JP 13536491 A JP13536491 A JP 13536491A JP H0663131 A JPH0663131 A JP H0663131A
Authority
JP
Japan
Prior art keywords
blood
filter
diameter
leukocyte removal
fibers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3135364A
Other languages
Japanese (ja)
Other versions
JPH0651063B2 (en
Inventor
Hiroyuki Watanabe
廣行 渡辺
Hiroshi Rikumaru
紘 陸丸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP59048173A priority Critical patent/JPS60193468A/en
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP3135364A priority patent/JPH0651063B2/en
Publication of JPH0663131A publication Critical patent/JPH0663131A/en
Publication of JPH0651063B2 publication Critical patent/JPH0651063B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

PURPOSE:To separate leucocyte from a large quantity of hemocyte floating liquid by simple operation, with good efficiency and by short time processing. CONSTITUTION:If nonwoven fabric prepared from fibers with diameter of less than 3mum and with bulk density from 0.15g/cm<3> to 0.50g/cm<3> or less is used, the contact area with the blood can be increased as compared with the conventional filter, and the longitudinal thickness required for removing leucocyte can be decreased so as to lessen a pressure loss of the filter, so that the above object can be achieved.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、血液、体液等の多量の
血球浮遊液から白血球を選択的に除去するための方法に
関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for selectively removing leukocytes from a large amount of blood cell suspension such as blood and body fluid.

【0002】[0002]

【従来の技術】近年、血液学、免疫学の発達により、従
来の全血輸血に代わって、患者が必要とする血液の成分
だけを与え、不要な成分は極力与えない成分輸血が注目
をあびている。成分輸血には、赤血球輸血、白血球輸
血、血小板輸血、血漿輸血などがあり、貧血、心臓及び
肺疾患の患者等に赤血球のみを輸注する症例は極めて多
い。その理由として、全血赤血球濃厚液を輸血された患
者が、悪寒、発熱、頭痛、吐き気などの副作用を示すこ
とが報告されている。これらの原因は、輸注される血液
中の白血球が有しているHLA抗原、ないしは組織抗原
と呼ばれる抗原と受血者の抗体との免疫反応、すなわ
ち、抗白血球抗体産生によるものと言われる。したがっ
て、赤血球輸血の場合には、白血球、血小板等、抗原と
なる物質をできるだけ除去した赤血球濃厚液を輸注する
ことが望ましい。
2. Description of the Related Art In recent years, due to the development of hematology and immunology, in place of conventional whole blood transfusion, attention has been paid to component transfusion that provides only the blood components required by the patient and does not give unnecessary components as much as possible. It is growing. Component transfusions include erythrocyte transfusion, leukocyte transfusion, platelet transfusion, plasma transfusion, and the like, and there are very many cases in which only erythrocytes are transfused to patients with anemia, heart and lung diseases, and the like. As a reason for this, it has been reported that patients transfused with whole blood red blood cell concentrate exhibit side effects such as chills, fever, headache and nausea. It is said that these causes are caused by an immune reaction between the HLA antigen, which is contained in leukocytes in the infused blood, or an antigen called a tissue antigen, and the antibody of the recipient, that is, anti-leukocyte antibody production. Therefore, in the case of transfusion of red blood cells, it is desirable to infuse a concentrated red blood cell liquid in which substances that become antigens such as white blood cells and platelets are removed as much as possible.

【0003】これらの知見より、現在、白血球、血小板
をできるだけ除去した濃厚赤血球を得る方法が種々検討
されている。この方法は、大別すると3通りある。一つ
には、遠心分離により白血球、血小板、血漿を分離し、
濃厚赤血球を得る方法、二つには、全血にデキストラン
を加え、赤血球を沈降させた後、白血球を含む血漿を除
去し、さらに、生理的食塩水でデキストランを洗浄除去
し、洗浄濃厚赤血球を得る方法、三つには、繊維を適当
に充填したフィルターで白血球を捕捉し、白血球除去濃
厚赤血球を得る方法である。
Based on these findings, various methods for obtaining concentrated red blood cells from which white blood cells and platelets are removed as much as possible are currently being studied. This method is roughly classified into three types. One is to separate white blood cells, platelets and plasma by centrifugation,
To obtain concentrated red blood cells, two methods are to add dextran to whole blood, sediment the red blood cells, remove plasma containing white blood cells, and then wash away dextran with physiological saline to remove washed concentrated red blood cells. The third method is to obtain leukocyte-depleted concentrated red blood cells by capturing leukocytes with a filter appropriately filled with fibers.

【0004】しかしながら、遠心分離法は、その装置が
高価であること、白血球および血小板を90%程度除去
するためには、生理食塩水での洗浄を3回以上くり返さ
なければならないこと、白血球を吸引せずに、分離した
赤血球を吸引して分離するため、赤血球の20%程度は
無駄となることに問題があるが、デキストラン沈降法も
白血球除去率を90%程度にするには、3回以上の生理
食塩水の洗浄とデキストランの洗浄が必要であり、時間
がかかり、操作性も難儀である。
However, the centrifuge method is expensive and requires that washing with physiological saline must be repeated three times or more in order to remove leukocytes and platelets by about 90%. Since the separated red blood cells are aspirated and separated without being aspirated, about 20% of the red blood cells are wasted, but the dextran sedimentation method also requires three times to achieve a leukocyte removal rate of about 90%. It is necessary to wash the physiological saline solution and the dextran as described above, which is time-consuming and difficult to operate.

【0005】繊維を充填したフィルター装置で白血球を
捕捉し、白血球のない赤血球に飛んだ赤血球浮遊液を得
るための方法としては、特公昭58−54125号およ
び特公昭58−54126号があるが、これらの発明
は、血液を変性させない合成繊維、半合成繊維、再生人
造繊維、無機繊維、天然繊維の少なくとも1種が、カラ
ムに0.15g/cm3 以下の密度で詰められた白血球分
離フィルター装置、および平均直径が10μm以下の血
液を変性させない合成繊維、半合成繊維、再生人造繊
維、無機繊維または天然繊維からなる白血球分離材とい
うものである。そして、繊維として、その表面に微小な
突起を有するような繊維の使用も開示されており、平均
直径(D)について、真円に換算した直径、すなわち、
そのものの重さをxg、長さをycm、密度ρg/cm3
すると、
Japanese Patent Publication No. 58-54125 and Japanese Examined Patent Publication No. 58-54126 are known as methods for capturing leukocytes with a filter device filled with fibers to obtain a red blood cell suspension containing leukocytes free of leukocytes. These inventions provide a leukocyte separation filter device in which at least one kind of synthetic fiber, semi-synthetic fiber, regenerated artificial fiber, inorganic fiber, and natural fiber that does not denature blood is packed in a column at a density of 0.15 g / cm 3 or less. , And a white blood cell separator having an average diameter of 10 μm or less that does not denature blood and is composed of synthetic fibers, semi-synthetic fibers, regenerated artificial fibers, inorganic fibers or natural fibers. The use of a fiber having minute projections on its surface is also disclosed as the fiber, and the diameter converted into a perfect circle with respect to the average diameter (D), that is,
If its weight is xg, its length is ycm, and its density is ρg / cm 3 , then

【0006】[0006]

【数1】 で定義されることが記載されている。[Equation 1] It is described that it is defined in.

【0007】上記白血球分離フィルター装置および白血
球分離材は、血液から簡単な操作で純度、収率良く白血
球を捕捉、除去できるという特徴があるが、実際に病院
で使用する大きさのフィルターでは、処理速度が5ml/
min 程度であり、200ml処理するのに約40分、50
0ml処理するのに100分程度かかり、処理時間として
長くかかりすぎるという問題の他、処理の間、血液を室
温放置すれば、血液の変性が進むという問題、さらに
は、処理速度を上げるには極端にフィルターの容量が大
きくなり、一定の大きさで繊維を0.15g/cm3 以上
詰めると、赤血球まで捕捉するため目詰まりし、極端に
処理速度が減少するという問題があった。
The above-mentioned leukocyte separation filter device and leukocyte separation material are characterized in that they can capture and remove leukocytes from blood with a high degree of purity and yield by simple operations. Speed is 5ml /
It takes about 40 minutes and 50 minutes to process 200 ml.
In addition to the problem that it takes about 100 minutes to process 0 ml and the processing time is too long, there is a problem that if the blood is left at room temperature during the process, the denaturation of the blood will proceed, and further it is extremely important to increase the processing speed. In addition, the capacity of the filter becomes large, and if the fiber is packed to a certain size of 0.15 g / cm 3 or more, there is a problem that the red blood cells are also clogged and the processing speed is extremely reduced.

【0008】[0008]

【発明が解決しようとする課題】本発明は、多量の血球
浮遊液から簡単な操作で、高い効率で、しかも、ごく短
時間の処理で白血球を分離除去する方法を提供すること
を目的とする。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a method for separating and removing leukocytes from a large amount of blood cell suspension with a simple operation, a high efficiency and a very short treatment. .

【0009】[0009]

【課題を解決するための手段】本発明者らは、上記目的
を達成するため鋭意検討した結果、直径が3μm未満の
繊維で形成され、嵩密度が0.15g/cm3 を超え0.
50g/cm3 以下の不織布を用いると、従来のものに比
較して血液との接触面積を大きくすると共に、白血球除
去に必要な縦方向の厚みを著しく短くすることができる
ので、フィルターの圧力損失を小さくすることができ、
その結果、処理時間が10分の1くらいと大巾に短縮さ
れる上に、高い効率で白血球を選択的に分離除去できる
ことを見出した。
Means for Solving the Problems As a result of intensive investigations by the present inventors in order to achieve the above object, the inventors of the present invention have formed a fiber having a diameter of less than 3 μm and having a bulk density of more than 0.15 g / cm 3 and a density of more than 0.15 g / cm 3 .
When a non-woven fabric of 50 g / cm 3 or less is used, the contact area with blood can be increased as compared with the conventional one, and the thickness in the longitudinal direction required for leukocyte removal can be significantly shortened. Can be smaller,
As a result, they have found that the treatment time can be greatly shortened to about one tenth and that leukocytes can be selectively separated and removed with high efficiency.

【0010】本発明によれば、繊維径が極めて細い繊維
からなる不織布を使用することにより、フィルター装置
の縦方向および横方向に対して、繊維を均密に充填する
ことができる。また、細い繊維を均密に充填できるた
め、太い繊維では考えられないほど充填密度を上げるこ
とが可能である。そのため、血球浮遊液との接触面積を
大きくすると共に、白血球除去に必要な縦方向の長さ
(厚み)を著しく短く、すなわち、薄くすることがで
き、その結果、血球浮遊液を流した場合のフィルターの
圧力損失が少なく、処理速度が速くなり、短時間処理が
できるのである。
According to the present invention, by using the non-woven fabric composed of fibers having an extremely small fiber diameter, the fibers can be uniformly packed in the longitudinal direction and the lateral direction of the filter device. Further, since the fine fibers can be uniformly packed, the packing density can be increased to a level unthinkable with the thick fibers. Therefore, the contact area with the blood cell suspension can be increased, and the length (thickness) in the longitudinal direction required for leukocyte removal can be significantly shortened, that is, can be thinned. As a result, when the blood cell suspension is flowed, The pressure loss of the filter is small, the processing speed is high, and the processing time is short.

【0011】また、直径が3μm未満という細径繊維の
不織布を用いることにより、フィルター内の繊維間隙を
一定かつ均密で、しかも小さくすることができるので、
血液のチャンネリングが防止でき、白血球の除去性能を
一段と向上させることが可能となる。さらに、フィルタ
ー装置の厚さを薄く、小型化することことが可能となる
ので、プライミングボリュームを小さくし、赤血球の回
収率を向上させる効果もある。また、処理速度が速く、
操作時間が短いことは、4℃保存の血液を室温で処理す
る場合、血液温度の上昇を防ぐことができ、血液の変性
防止等にも効果がある。さらに、不織布を用いることに
より、処理時に出る糸くずがなくなり、輸血時の糸くず
の混入が防止できるという効果もある。
Further, by using a non-woven fabric of fine fibers having a diameter of less than 3 μm, the fiber gaps in the filter can be made uniform, uniform and small.
Blood channeling can be prevented, and leukocyte removal performance can be further improved. Furthermore, since the thickness of the filter device can be reduced and downsized, the priming volume can be reduced and the recovery rate of red blood cells can be improved. Also, the processing speed is fast,
When the operation time is short, when the blood stored at 4 ° C. is treated at room temperature, it is possible to prevent the blood temperature from rising and it is also effective in preventing the denaturation of blood. Furthermore, by using a non-woven fabric, there is an effect that the lint generated during the treatment is eliminated and the lint can be prevented from being mixed during the blood transfusion.

【0012】本発明において使用する不織布フィルター
を構成する繊維は、血液を変性させない合成繊維であ
り、ポリアミド、芳香族ポリアミド、ポリエステル、ポ
リアクリロニトリル系、ポリトリフルオロクロルエチレ
ン、ポリメチルメタアクリレート、ポリスチレン、ポリ
エチレン、ポリプロピレンなどがある。そして、直径が
3μm未満の繊維を作るには、一般的には難しいが、溶
融ブロー法(melt-blowing process) があり、この方法
により、本発明に用いるフィルターを構成する直径が3
μm未満の繊維を作成することができる。しかし、本発
明に用いるフィルターを構成する3μm未満の繊維の製
法は、この方法に限定されるものではない。
The fibers constituting the non-woven fabric filter used in the present invention are synthetic fibers that do not denature blood, such as polyamide, aromatic polyamide, polyester, polyacrylonitrile, polytrifluorochloroethylene, polymethylmethacrylate, polystyrene, Examples include polyethylene and polypropylene. Although it is generally difficult to produce fibers having a diameter of less than 3 μm, there is a melt-blowing process, and by this method, the diameter of the filter used in the present invention is 3
Fibers less than μm can be made. However, the method for producing fibers having a size of less than 3 μm, which constitutes the filter used in the present invention, is not limited to this method.

【0013】本発明に用いる不織布は、繊維が繊維の互
いのもつれによりその位置に固定されているものである
ことが好ましい。不織布とするための繊維環の固定法と
しては、これらの繊維の融点付近の熱を加えて熱固着さ
せたり、接着剤による固定法があり、これらは勿論、本
発明で用いる不織布に使用できるが、本発明で用いる繊
維のように繊維が細くなると、エアーブロー法、高圧蒸
気ブロー法などにより、繊維を互いにもつれさせるだけ
で繊維間が固定され、このように作成した不織布は、例
えば、破壊するような大きな力を加えない限り安定であ
り、血液処理にも充分耐えることができる。したがっ
て、このような完全に固着させないエアーブロー法、高
圧蒸気ブロー法などによる単に繊維を互いにもつれさせ
るだけの繊維の固定法が好ましく採用される。
The non-woven fabric used in the present invention is preferably one in which the fibers are fixed in place by the entanglement of the fibers. As a method for fixing the fiber ring for forming the nonwoven fabric, there is a fixing method by applying heat in the vicinity of the melting point of these fibers to fix them by heat or a fixing method with an adhesive, which can of course be used for the nonwoven fabric used in the present invention. When the fibers become thin like the fibers used in the present invention, the fibers are fixed only by entanglement of the fibers with each other by an air blow method, a high pressure steam blow method or the like, and the non-woven fabric thus created is, for example, destroyed. It is stable as long as it does not exert such a large force, and can withstand blood treatment sufficiently. Therefore, a method of fixing the fibers, which simply entangles the fibers with each other, such as an air blow method or a high pressure steam blow method, which does not completely fix them, is preferably adopted.

【0014】本発明に用いる不織布を構成する繊維の直
径は3μm未満であり、好ましくは0.1μmから3μ
m未満、さらに好ましくは0.1μmから2.0μmの
範囲である。繊維の直径が0.1μmより小さい場合
は、実際には作成が難しいが、均密に充填すると繊維間
隙が狭小になりすぎて、白血球と共に赤血球も捕捉され
てしまい、目詰まりを生じ、処理速度が極端に減少して
しまうことになる。繊維の直径が3μm以上の場合は、
充填密度を上げて、繊維間隙を小さくすることが必要で
あり、例えば、直径が3μm以上の繊維では、0.50
g/cm3 を超える充填密度にしないと白血球の除去率が
低下してしまう。さらには、充填密度を高くするため、
高圧下で充填することになり、繊維の破壊が生じてしま
うことになる。また、一定容積での血液接触面積が小さ
いため、白血球除去フィルターの容積が著しく大きくな
ってしまい、病院では取扱いが難しい。
The fibers constituting the nonwoven fabric used in the present invention have a diameter of less than 3 μm, preferably 0.1 μm to 3 μm.
It is less than m, and more preferably in the range of 0.1 μm to 2.0 μm. If the diameter of the fiber is smaller than 0.1 μm, it is difficult to make it in practice, but if it is packed evenly, the fiber gap will become too narrow, and red blood cells will be captured together with white blood cells, resulting in clogging and processing speed. Will be extremely reduced. If the fiber diameter is 3 μm or more,
It is necessary to increase the packing density to reduce the fiber gap, and for example, for fibers with a diameter of 3 μm or more, 0.50
Unless the packing density exceeds g / cm 3 , the leukocyte removal rate will decrease. Furthermore, in order to increase the packing density,
It will be filled under high pressure, and the fiber will be broken. Further, since the blood contact area in a fixed volume is small, the volume of the leukocyte removal filter becomes extremely large, which makes it difficult to handle in a hospital.

【0015】本発明に用いる不織布の嵩密度は、0.1
5g/cm3 を超え0.50g/cm3以下であることが必
要であり、好ましくは0.20g/cm3 から0.30g
/cm3 の範囲である。不織布の嵩密度が0.15g/cm
3 より小さい場合は、例えば、50ml/min という高速
処理になると白血球が洩れてくる。また、不織布の嵩密
度が0.50g/cm3 より大きくなると、繊維間隙が緻
密になりすぎて、赤血球も捕捉されるようになり、赤血
球の回収率が低下してくる。
The nonwoven fabric used in the present invention has a bulk density of 0.1.
It is necessary to exceed 5 g / cm 3 and 0.50 g / cm 3 or less, preferably 0.20 g / cm 3 to 0.30 g.
The range is / cm 3 . Nonwoven fabric bulk density is 0.15g / cm
If it is less than 3 , white blood cells will leak at a high speed of 50 ml / min. When the bulk density of the non-woven fabric is larger than 0.50 g / cm 3 , the fiber gap becomes too dense and red blood cells are also trapped, resulting in a low red blood cell recovery rate.

【0016】本発明に用いる不織布の厚さは、血球浮遊
液の高速処理のためには1mmから30mm、好ましくは1
mmから20mm、さらに好ましくは2mmから10mmの範囲
である。不織布の厚さが1mmより薄くなると、白血球の
捕捉が十分ではなく、白血球の捕捉率が低下してくる。
また、不織布の厚さが30mmより厚くなると、圧力損失
が大きくなり、処理速度が低下してくる。
The thickness of the non-woven fabric used in the present invention is 1 mm to 30 mm, preferably 1 for high-speed treatment of blood cell suspension.
The range is from mm to 20 mm, more preferably from 2 mm to 10 mm. If the thickness of the non-woven fabric is less than 1 mm, the leukocytes are not sufficiently captured and the leukocyte capture rate decreases.
If the thickness of the non-woven fabric is greater than 30 mm, the pressure loss will increase and the processing speed will decrease.

【0017】本発明に用いる不織布フィルター面積は、
血球浮遊液の高速処理のためには、繊維間の間隙部を含
めた血液入口側の総面積が10cm2 /血液500mlから
2000cm2 /血液500ml、好ましくは20cm2 /血
液500mlから1000cm2/血液500ml、さらに好
ましくは30cm2 /血液500mlから300cm2 /血液
500mlの範囲である。フィルター面積が10cm2 /血
液500mlより小さいと、白血球除去フィルターの表面
が白血球で飽和されてくるため、処理速度が遅くなって
くる。また、フィルター面積が2000cm2 /血液50
0mlより大きい場合は、白血球除去処理後の白血球除去
フィルター内の赤血球回収のための生理食塩水が多量に
必要になったり、白血球除去フィルター内に残る赤血球
も多くなるため赤血球の回収率が低下してくる。
The area of the non-woven fabric filter used in the present invention is
For high-speed processing of the blood cell suspension includes blood inlet side of the total area of 10 cm 2 / blood 500ml from 2000 cm 2 / blood 500ml including the gap between the fibers, preferably 20 cm 2 / blood 500ml from 1000 cm 2 / blood 500ml, more preferably in the range of 300 cm 2 / blood 500ml of 30 cm 2 / blood 500ml. And filter area is less than 10 cm 2 / blood 500 ml, since the surface of the leukocyte removal filter comes saturated with leukocytes, processing speed becomes slow. The filter area is 2000 cm 2 / blood 50
If it is larger than 0 ml, a large amount of physiological saline is required to collect red blood cells in the white blood cell removal filter after the white blood cell removal treatment, or the number of red blood cells remaining in the white blood cell removal filter increases, resulting in a low red blood cell recovery rate. Come on.

【0018】なお、本発明に用いる不織布の嵩密度と
は、均一な不織布1cm3 当たりの、その重さを測定した
値を言う。本発明でいう血球浮遊液とは、血液や体液、
たとえば腹水や骨髄液それ自身の他、これらの液に何ら
かの処理、例えばデキストランやヒドロキシエチルスタ
ーチなどの赤血球凝集剤のような血球凝集剤を加えて得
た血球浮遊液や、密度勾配遠心分離などのような遠心分
離操作により得た血球浮遊液、細胞電気泳動により得ら
れた血球浮遊液などをいう。
The bulk density of the nonwoven fabric used in the present invention is a value obtained by measuring the weight of a uniform nonwoven fabric per cm 3 . The blood cell suspension referred to in the present invention means blood or body fluid,
For example, in addition to ascites and bone marrow fluid itself, some treatment to these fluids, for example, a hemagglutination suspension obtained by adding a hemagglutination agent such as a hemagglutination agent such as dextran or hydroxyethyl starch, or density gradient centrifugation, etc. A blood cell suspension obtained by such a centrifugation operation, a blood cell suspension obtained by cell electrophoresis, and the like.

【0019】本願発明の目的とする多量の血球浮遊液か
ら簡単な操作で収率よく、しかもごく短時間の処理で白
血球を選択的に捕捉除去するには、繊維の直径が3μm
未満で、嵩密度が0.15g/cm3 を超え、0.50g
/cm3 以下の薄い不織布からなるフィルターに該多量の
血液を流すことが必要であり、好ましくは用いる不織布
が繊維の互いのもつれによりその位置に固定されている
ものであって、しかも不織布の嵩密度、およびフィルタ
ー面積が前記の範囲にあることである。
In order to selectively capture and remove leukocytes from a large amount of a blood cell suspension, which is the object of the present invention, by a simple operation with a high yield and in a very short time, the fiber diameter is 3 μm.
And the bulk density is more than 0.15 g / cm 3 and 0.50 g
It is necessary to flow a large amount of blood through a filter made of a thin non-woven fabric of not more than 1 cm 3 / cm 3 , preferably the non-woven fabric used is fixed in its position by the entanglement of fibers, and the bulk of the non-woven fabric is large. The density and the filter area are within the above ranges.

【0020】以下、本願発明の白血球の選択的除去方法
に用いるフィルターおよび該フィルターを内蔵したフィ
ルター装置の詳細を図面を参照して説明する。図1およ
び図2は、本発明の白血球の選択的除去方法に用いるフ
ィルター装置の一実施態様を示し、図3および図4は、
別の実施態様を示すものである。図1および図2におい
て、1はフィルター装置本体で、二つの丸盆状枠体2,
2’が空胴部を形成するように、リング部剤3で嵌合
し、丸盆状枠体2,2’の内面には、それぞれ多数の突
条4,4’が形成され、その内側に、メッシュ状支持材
5,5’に挟まれて、不織布からなるフィルター6が設
けられている。7は一方の丸盆状枠体2に設けられた血
液流入管、8は他方の丸盆条枠体2’に設けられた血液
流出管であり、9,9’はパッキングである。そして、
フィルター6はメッシュ状支持材5,5’によって、嵩
密度が0.15g/cm3 を超え0.50g/cm3 以下の
範囲に保持されている。
The details of the filter used in the method for selectively removing leukocytes of the present invention and the filter device incorporating the filter will be described below with reference to the drawings. 1 and 2 show one embodiment of a filter device used in the method for selectively removing leukocytes of the present invention, and FIGS. 3 and 4 show
9 illustrates another embodiment. In FIG. 1 and FIG. 2, 1 is a filter device main body, and two round tray-shaped frame bodies 2,
2'is fitted with a ring agent 3 so as to form a cavity, and a large number of ridges 4 and 4'are formed on the inner surfaces of the round tray frame bodies 2 and 2 ', respectively. In addition, a filter 6 made of a non-woven fabric is provided between the mesh-shaped support materials 5 and 5 '. Reference numeral 7 is a blood inflow pipe provided in one round tray frame 2, 2 is a blood outflow pipe provided in the other round tray frame 2 ', and 9 and 9'are packings. And
The bulk density of the filter 6 is kept in the range of more than 0.15 g / cm 3 and 0.50 g / cm 3 or less by the mesh-shaped support materials 5 and 5 '.

【0021】図3および図4のフィルター装置も、前記
フィルター装置とほぼ同様であるが、血液流入管13お
よび血液流出管14が丸盆状枠体10,10’のそれぞ
れ中心部に設けられ、空胴部には、メッシュ状支持材1
1,11’に挟まれて、不織布からなるフィルター12
が設けられている。15,15’はパッキングである。
The filter device of FIGS. 3 and 4 is substantially the same as the filter device, except that a blood inflow pipe 13 and a blood outflow pipe 14 are provided at the central portions of the round tray frames 10 and 10 ', respectively. Mesh support material 1 in the cavity
Filter 12 made of non-woven fabric sandwiched between 1, 11 '
Is provided. 15, 15 'are packings.

【0022】メッシュ状支持材は、血液の流体が均一流
になるようにメッシュ状にしており、流路規制部の役割
もしている。血液は血液流入管7あるいは13より導入
され、メッシュ状支持材5あるいは11を通過すること
により、均一流となり、次にフィルター6あるいは12
に導入され、白血球および血小板等が捕捉され、赤血球
および血漿が通過し、白血球が選択的に除去されて赤血
球が濃厚となった血液は、メッシュ状支持材5’あるい
は11’を通過することにより、さらに均一流となり、
血液流出管8あるいは14から回収されることになる。
The mesh-shaped support member is formed in a mesh shape so that the blood fluid can flow uniformly, and also functions as a flow path regulating portion. Blood is introduced from the blood inflow pipe 7 or 13 and passes through the mesh-shaped support material 5 or 11 to become a uniform flow, and then the filter 6 or 12
The blood which has been introduced into the blood vessel, has leukocytes and platelets trapped therein, erythrocytes and plasma have passed therethrough, and leukocytes have been selectively removed so that the erythrocytes have become thick. By passing through the mesh-shaped support material 5 ′ or 11 ′, , A more uniform flow,
It will be collected from the blood outflow pipe 8 or 14.

【0023】蒸気フィルターは、繊維表面の粘着性、荷
電性、疎水性および繊維間隙などにより、血液中の白血
球、血小板等を選択的に捕捉し、赤血球、血漿のみを通
過させるもので、繊維表面の粘着性、荷電性、疎水性の
効果は、繊維間隙に大きく影響される。さらに白血球、
血小板等の捕捉性および赤血球、血漿の通過性は、不織
布の嵩密度に関係する。健康人の全血、PRC液、およ
び牛の全血、PRC液を使用した詳細な試験結果によれ
ば、不織布の嵩密度は、0.15g/cm3 を超え0.5
0g/cm3 以下が適し、特にポリエステル糸からなる不
織布の嵩密度は0.20g/cm3 から0.30g/cm3
程度が好ましい。
The vapor filter selectively captures leukocytes, platelets and the like in blood and allows only red blood cells and plasma to pass through due to the adhesiveness, chargeability, hydrophobicity and fiber gaps of the fiber surface. The effect of tackiness, chargeability, and hydrophobicity of is greatly influenced by fiber gap. White blood cells,
The ability to capture platelets and the ability to pass red blood cells and plasma are related to the bulk density of the nonwoven fabric. According to detailed test results using whole blood of healthy persons, PRC solution, and whole blood of bovine, PRC solution, the bulk density of the non-woven fabric is more than 0.15 g / cm 3 and 0.5.
0 g / cm 3 or less is suitable, and the bulk density of the non-woven fabric made of polyester yarn is 0.20 g / cm 3 to 0.30 g / cm 3
A degree is preferable.

【0024】図5は、本発明の白血球の選択的除去方法
の一実施態様を示すものである。人体から採取された血
液は、採血バッグ16から落差圧により、回路17を通
り、本発明の白血球除去フィルターによるフィルター装
置18に供給される。フィルター装置18に導入された
血液は、フィルター装置内の不織布よりなる白血球除去
フィルターにより、白血球、血小板等が捕捉され、実質
的に赤血球と血漿とからなる血液となり、回路19を通
過後、回収バッグ20に供給される。赤血球の回収率を
より高める場合は、あらかじめ用意した生理食塩水バッ
グ21より、同様にして、回路22を通してフィルター
装置18に導入し、回路および白血球除去フィルターに
一部残存している赤血球を回収できる。なお、23は回
収バッグ、24は調整バルブである。以上は、人体から
採取された血液が採血バッグに入っている例を示した
が、直接、人体より血液を採取し、循環ポンプ等によ
り、フィルター装置に導入し、白血球などを除去した赤
血球、血漿が主となる血液を再び体内にもどすこともで
きる。
FIG. 5 shows one embodiment of the method for selectively removing leukocytes of the present invention. Blood collected from the human body passes through the circuit 17 by the drop pressure from the blood collection bag 16 and is supplied to the filter device 18 including the leukocyte removal filter of the present invention. The white blood introduced into the filter device 18 is captured by the white blood cell removal filter made of non-woven fabric in the filter device to become white blood consisting essentially of red blood cells and plasma, and after passing through the circuit 19, a collection bag. 20. When the recovery rate of erythrocytes is further enhanced, the erythrocytes partially remaining in the circuit and the leukocyte removal filter can be recovered from the physiological saline bag 21 prepared in advance and similarly introduced into the filter device 18 through the circuit 22. . In addition, 23 is a collection bag and 24 is an adjustment valve. The above shows an example in which blood collected from the human body is contained in a blood collection bag, but blood is directly collected from the human body and introduced into a filter device by a circulation pump or the like to remove red blood cells and the like, red blood cells and plasma. The main blood can be returned to the body again.

【0025】以上述べたように、本発明による白血球の
選択的除去方法は、多量の血液、血球浮遊液から簡単な
操作で、収率よく、しかもごく短時間の処理で、白血球
を分離、除去できるものである。以下、実施例を挙げて
説明する。
As described above, the method for selectively removing leukocytes according to the present invention separates and removes leukocytes from a large amount of blood or hemocyte suspension by a simple operation with high yield and in a very short time. It is possible. Examples will be described below.

【0026】[0026]

【実施例】【Example】

実施例1 直径1.2μmのポリエステル繊維を溶融ブロー法で作
成した嵩密度0.18g/cm3 の繊維塊が繊維の互いの
もつれによってその位置に固定されている不織布を、直
径110mm、厚さ7mmの円柱状に切断し、有効内径10
0mm(有効内径=血液または血球浮遊液が実際にフィル
ター表面に接触する部分の径を示す。以後の実施例にお
いても同じ)、厚さ11mmのカラム中に固定した。30
0mlの採血バッグ2個からそれぞれ落差800mmの位置
に、上記の白血球除去フィルター装置をつけ、さらに8
00mm下方に1リットルの輸液バッグをつけて、処理し
た液を貯蔵する回収バッグとし、その間をそれぞれ内径
3mm、外径5mmのチューブで連結した処理装置を作成し
た。この処理装置の採血バッグ2個に、A型の健康人の
ヘマトクリット38%の新鮮CPD液添加血液全血25
0mlずつを入れ、落差を利用した自然落下法により、室
温25℃で1バッグずつ順番に白血球除去処理を行っ
た。
Example 1 A nonwoven fabric in which a polyester fiber having a diameter of 1.2 μm was prepared by a melt-blowing method and a fiber mass having a bulk density of 0.18 g / cm 3 was fixed in its position by the entanglement of the fibers was 110 mm in diameter and thickness. Cut to a 7 mm column shape and have an effective inner diameter of 10
It was fixed in a column having a thickness of 0 mm (effective inner diameter = the diameter of a portion where blood or blood cell suspension actually contacts the filter surface. The same applies to the following Examples) and a column having a thickness of 11 mm. Thirty
Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 0 ml blood collection bags, and add 8
A 1-liter infusion bag was attached to the lower part of 00 mm to form a collection bag for storing the treated liquid, and a processing device was prepared by connecting the inside with a tube having an inner diameter of 3 mm and an outer diameter of 5 mm. 25 pieces of hematocrit of type A healthy person with fresh CPD solution added to two blood collection bags of this processing device 25 whole blood
The leukocyte-removing treatment was carried out one by one at a room temperature of 25 ° C. by a free fall method using a drop.

【0027】次に、生理食塩水90mlを自然落下法によ
り、この白血球除去フィルター装置に流し、フィルター
内の赤血球を回収した。その結果、この新鮮血液500
mlの処理時間は6分35秒であり、処理速度にして76
ml/分という高流速であった。また、白血球除去率は9
9.7%であり、赤血球回収率は95%であった。
Next, 90 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 500
The processing time of ml is 6 minutes and 35 seconds, and the processing speed is 76
The flow rate was as high as ml / min. The leukocyte removal rate is 9
It was 9.7%, and the red blood cell recovery rate was 95%.

【0028】比較例1 直径が9.6μm、長さが40mmから70mmのポリエス
テル繊維を、直径が30mm、長さ100mmのカラムに9
gを均一に詰めた白血球除去フィルター装置(嵩密度
0.13g/cm3 )を作成した。300mlの採血バッグ
2個からそれぞれ落差800mmの位置に、上記の白血球
除去フィルター装置をつけ、さらに800mm下方に1リ
ットルの輸液バッグをつけて、処理した血液を貯蔵する
回収バッグとし、その間をそれぞれ内径3mm、外径5mm
のチューブで連結した処理装置を作成した。この処理装
置の採血バッグ2個に、A型の健康人のヘマトクリット
38%の新鮮CPD液添加血液全血250mlずつを入
れ、落差を利用した自然落下法により、室温25℃で1
バッグずつ順番に白血球除去処理を行った。
Comparative Example 1 Polyester fiber having a diameter of 9.6 μm and a length of 40 mm to 70 mm was placed in a column having a diameter of 30 mm and a length of 100 mm.
A leukocyte removal filter device (bulk density 0.13 g / cm 3 ) in which g was uniformly packed was prepared. Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 300 ml blood collection bags, and further attach a 1 liter infusion bag 800 mm below to make a collection bag for storing the treated blood, and each of them has an inner diameter between them. 3 mm, outer diameter 5 mm
The processing device connected with the tube of was produced. 250 ml of fresh blood containing 38% hematocrit of fresh type CPD solution of whole blood of type A healthy person is put into 2 blood collection bags of this processing device, and the free fall method using the drop is performed at room temperature at 25 ° C.
The leukocyte removal treatment was performed in order on each bag.

【0029】次に、生理食塩水80mlを自然落下法によ
り、この白血球除去フィルター装置に流し、フィルター
内の赤血球を回収した。その結果、この新鮮血液500
mlの処理時間は1時間32分35秒であり、処理速度に
して5.4ml/分であった。また、白血球除去率は9
3.2%、赤血球回収率は95%であった。実施例1に
よれば、本発明の白血球除去フィルターは、従来の白血
球除去フィルターと比較して約14倍の高速処理であ
り、白血球除去率が良く、赤血球回収率も従来法と同程
度の優秀な性能であった。
Next, 80 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 500
The processing time of ml was 1 hour 32 minutes 35 seconds, and the processing rate was 5.4 ml / minute. The leukocyte removal rate is 9
The red blood cell recovery rate was 3.2% and the red blood cell recovery rate was 95%. According to Example 1, the leukocyte depletion filter of the present invention is about 14 times as fast as the conventional leukocyte depletion filter, has a good leukocyte depletion rate, and has an excellent red blood cell recovery rate comparable to that of the conventional method. It was a good performance.

【0030】実施例2 直径1.8μmのポリエステル繊維を溶融ブロー法で作
成した嵩密度0.22g/cm3 の繊維塊が繊維の互いの
もつれによってその位置に固定されている不織布を、直
径78mm、厚さ4mmの円柱状に切断し、有効内径68m
m、厚さ8mmのカラム中に固定した。300mlの採血バ
ッグ2個からそれぞれ落差800mmの位置に、上記の白
血球除去フィルター装置をつけ、さらに800mm下方に
1リットルの輸液バッグをつけて、処理した液を貯蔵す
る回収バッグとし、その間をそれぞれ内径3mm、外径5
mmのチューブで連結した処理装置を作成した。この処理
装置の採血バッグ2個に、B型の健康人のヘマトクリッ
ト42%の新鮮ACD−A液添加血液全血250mlずつ
を入れ、落差を利用した自然落下法により、室温25℃
で1バッグずつ順番に白血球除去処理を行った。
Example 2 A non-woven fabric in which polyester fibers having a diameter of 1.8 μm were prepared by a melt-blowing method and fiber lumps having a bulk density of 0.22 g / cm 3 were fixed at the positions by entanglement of the fibers were prepared. , Cut into a cylindrical shape with a thickness of 4 mm and an effective inner diameter of 68 m
It was fixed in a column of m and 8 mm in thickness. Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 300 ml blood collection bags, and further attach a 1 liter infusion bag 800 mm below to form a collection bag for storing the treated liquid, with the inside diameters between them. 3 mm, outer diameter 5
A processing device connected with a mm tube was created. 250 ml of fresh ACD-A liquid-added whole blood of 42% hematocrit of type B healthy person was put in two blood collection bags of this processing device, and the temperature was 25 ° C at room temperature by a free fall method using a drop.
Then, leukocyte removal treatment was performed one bag at a time.

【0031】次に、生理食塩水40mlを自然落下法によ
り、白血球除去フィルター装置に流し、フィルターの赤
血球を回収した。その結果、この新鮮血液500mlの処
理時間は7分15秒であり、処理速度にして69ml/分
という高流速であった。また、白血球除去率は100
%、赤血球回収率は98%であった。
Next, 40 ml of physiological saline was flown through a leukocyte removal filter device by the free fall method to collect red blood cells on the filter. As a result, the processing time of 500 ml of this fresh blood was 7 minutes and 15 seconds, and the processing speed was as high as 69 ml / minute. The leukocyte removal rate is 100
%, And the red blood cell recovery rate was 98%.

【0032】比較例2 直径が7.2μm、長さが40mmから70mmのポリアミ
ド繊維(ナイロン−66)を、直径が36mm、長さ70
mmのカラムに6.6gを均一に詰めた白血球除去フィル
ター装置(嵩密度0.093g/cm3 )を作成した。3
00mlの採血バッグ2個からそれぞれ落差800mmの位
置に、上記の白血球除去フィルター装置をつけ、さらに
800mm下方に1リットルの輸液バッグをつけて、処理
した血液を貯蔵する回収バッグとし、その間をそれぞれ
内径3mm、外径5mmのチューブで連結した処理装置を作
成した。この処理装置の採血バッグ2個に、B型の健康
人のヘマトクリット42%の新鮮ACD−A液添加血液
全血250mlずつを入れ、落差を利用した自然落下法に
より、室温25℃で1バッグずつ順番に白血球除去処理
を行った。
Comparative Example 2 Polyamide fiber (nylon-66) having a diameter of 7.2 μm and a length of 40 mm to 70 mm was used, and a diameter of 36 mm and a length of 70 were used.
A leukocyte removal filter device (bulk density 0.093 g / cm 3 ) was prepared by uniformly packing 6.6 g in a mm column. Three
Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the two 00 ml blood collection bags, and further attach the 1 liter infusion bag 800 mm below to form a collection bag for storing the treated blood, and the space between them is the inner diameter. A processing device connected by a tube having a diameter of 3 mm and an outer diameter of 5 mm was prepared. 250 ml of fresh ACD-A solution-added whole blood of 42% hematocrit of type B healthy person was put into 2 blood collection bags of this processing device, and 1 bag at room temperature 25 ° C by the free fall method using the drop. Leukocyte removal treatment was performed in order.

【0033】次に、生理食塩水80mlを自然落下法によ
り、この白血球除去フィルター装置に流し、フィルター
内の赤血球を回収した。その結果、この新鮮血液500
mlの処理時間は1時間24分45秒であり、処理速度に
して5.9ml/分であった。また、白血球除去率は9
5.1%、赤血球回収率は94%であった。実施例2に
よれば、本発明の白血球除去フィルターは、従来の白血
球除去フィルターと比較して約12倍の高速処理であ
り、白血球除去率が良く、赤血球回収率も従来法と同程
度の優秀な性能であった。
Next, 80 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 500
The processing time of ml was 1 hour 24 minutes 45 seconds, and the processing rate was 5.9 ml / minute. The leukocyte removal rate is 9
The red blood cell recovery rate was 5.1% and the red blood cell recovery rate was 94%. According to the second embodiment, the leukocyte removal filter of the present invention is about 12 times faster than the conventional leukocyte removal filter, has a good leukocyte removal rate, and has an excellent red blood cell recovery rate comparable to that of the conventional method. It was a good performance.

【0034】実施例3 直径0.8μmのポリアミド繊維(ナイロン−66)を
溶融ブロー法で作成した嵩密度0.16g/cm3 の繊維
塊が繊維の互いのもつれによってその位置に固定されて
いる不織布を、直径100mm、厚さ2mmの円柱状に切断
し、有効内径90mm、厚さ6mmのカラム中に固定した。
300mlの採血バッグ2個からそれぞれ落差800mmの
位置に、上記の白血球除去フィルター装置をつけ、さら
に800mm下方に1リットルの輸液バッグをつけて、処
理した液を貯蔵する回収バッグとし、その間をそれぞれ
内径3mm、外径5mmのチューブで連結した処理装置を作
成した。この処理装置の採血バッグ2個に、A型の健康
人のヘマトクリット45%の新鮮CPD液添加血液全血
250mlずつを入れ、落差を利用した自然落下法によ
り、室温25℃で1バッグずつ順番に白血球除去処理を
行った。
Example 3 Polyamide fibers (nylon-66) having a diameter of 0.8 μm prepared by a melt-blowing method and having a bulk density of 0.16 g / cm 3 are fixed at their positions by the entanglement of the fibers. The non-woven fabric was cut into a column having a diameter of 100 mm and a thickness of 2 mm and fixed in a column having an effective inner diameter of 90 mm and a thickness of 6 mm.
Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 300 ml blood collection bags, and further attach a 1 liter infusion bag 800 mm below to form a collection bag for storing the treated liquid, with the inside diameters between them. A processing device connected by a tube having a diameter of 3 mm and an outer diameter of 5 mm was prepared. 250 ml of fresh CPD solution-added whole blood of 45% hematocrit of type A healthy person is put in two blood collection bags of this processing device, and one bag is sequentially placed at room temperature of 25 ° C. by the free fall method using the drop. Leukocyte removal treatment was performed.

【0035】次に、生理食塩水50mlを自然落下法によ
り、この白血球除去フィルター装置に流し、フィルター
内の赤血球を回収した。その結果、この新鮮血液500
mlの処理時間は6分29秒であり、処理速度にして77
ml/分という高流速であった。また、白血球除去率は9
9.9%であり、赤血球回収率は98%であった。
Next, 50 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 500
The processing time of ml is 6 minutes 29 seconds, and the processing speed is 77
The flow rate was as high as ml / min. The leukocyte removal rate is 9
It was 9.9%, and the red blood cell recovery rate was 98%.

【0036】比較例3 直径が5.2μm、長さが40mmから70mmのアクリロ
ニトリル系合成繊維を、直径が80mm、長さ40mmのカ
ラムに18gを均一に詰めた白血球除去フィルター装置
(嵩密度0.090g/cm3 )を作成した。300mlの
採血バッグ2個からそれぞれ落差800mmの位置に、上
記の白血球除去フィルターをつけ、さらに800mm下方
に1リットルの輸液バッグをつけて、処理した血液を貯
蔵する回収バッグとし、その間をそれぞれ内径3mm、外
径5mmのチューブで連結した処理装置を作成した。この
処理装置の採血バッグ2個に、A型の健康人のヘマトク
リット45%の新鮮CPD液添加血液全血250mlずつ
を入れ、落差を利用した自然落下法により、室温25℃
で1バッグずつ順番に白血球除去処理を行った。
Comparative Example 3 A leukocyte-removing filter device (bulk density: 0.1 μm) in which a column having a diameter of 80 mm and a length of 40 mm was uniformly packed with 18 g of an acrylonitrile-based synthetic fiber having a diameter of 5.2 μm and a length of 40 mm to 70 mm (bulk density: 0. 090 g / cm 3 ) was prepared. Attach the above leukocyte removal filter at the position of 800 mm drop from each of the 300 ml blood collection bags, and further attach a 1 liter infusion bag 800 mm below to make a collection bag for storing the treated blood, and the space between them is 3 mm inside diameter. , A processing device connected with a tube having an outer diameter of 5 mm was prepared. Two blood collection bags of this processing device were filled with 250 ml each of fresh blood of C-type CPD solution containing 45% hematocrit of type A healthy person, and the temperature was 25 ° C at room temperature by the free fall method.
Then, leukocyte removal treatment was performed one bag at a time.

【0037】次に、生理食塩水210mlを自然落下法に
より、この白血球除去フィルター装置に流し、フィルタ
ー内の赤血球を回収した。その結果、この新鮮血液50
0mlの処理時間は19分14秒であり、処理速度にして
26ml/分であった。また、白血球除去率は68.4
%、赤血球回収率は91.3%であった。実施例3によ
れば、本発明の白血球除去フィルターは78ml/分とい
う高速処理であった。また、従来法で高速処理を試みた
が、処理速度は26ml/分と速くしたところ、白血球除
去率が低下した。したがって、従来法では処理速度を早
くするには限度があり、本発明のような高速処理はでき
ない。
Next, 210 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 50
The processing time of 0 ml was 19 minutes and 14 seconds, and the processing speed was 26 ml / minute. The leukocyte removal rate is 68.4.
%, And the red blood cell recovery rate was 91.3%. According to Example 3, the leukocyte removal filter of the present invention was a high-speed treatment of 78 ml / min. Although a high-speed treatment was attempted by the conventional method, when the treatment speed was increased to 26 ml / min, the leukocyte removal rate decreased. Therefore, the conventional method has a limit in increasing the processing speed, and high-speed processing as in the present invention cannot be performed.

【0038】実施例4 直径2.8μmのポリエステル繊維を溶融ブロー法にて
作成した嵩密度0.28g/cm3 の不織布を製造する
際、溶融ブロー時250℃で2秒間乾熱処理し、繊維の
互いにもつれあった接点を熱固着した不織布を作成し
た。この不織布を、直径160mm、厚さ8mmの円柱状に
切断し、有効内径150mm、厚さ12mmのカラム中に固
定した。300mlの採血バッグ2個からそれぞれ落差8
00mmの位置に、上記の白血球除去フィルターをつけ、
さらに800mm下方に1リットルの輸液バッグをつけ
て、処理した液を貯蔵する回収バッグとし、その間をそ
れぞれ内径3mm、外径5mmのチューブで連結した処理装
置を作成した。この処理装置の採血バッグ2個に、O型
の健康人のヘマトクリット64%の新鮮CPD液添加血
液濃厚液(遠心分離法により一部血漿を除去したもの)
の1日4℃で保存したものを200mlずつを入れ、落差
を利用した自然落下法により、4℃の冷蔵庫より取り出
し、ただちに、室温10℃にて1バッグずつ順番に白血
球除去処理を行った。
Example 4 When a nonwoven fabric having a bulk density of 0.28 g / cm 3 prepared by melt-blowing a polyester fiber having a diameter of 2.8 μm was manufactured, a dry heat treatment was performed at 250 ° C. for 2 seconds during the melt-blowing, A non-woven fabric was produced in which the contact points entangled with each other were heat-fixed. This non-woven fabric was cut into a cylindrical shape having a diameter of 160 mm and a thickness of 8 mm and fixed in a column having an effective inner diameter of 150 mm and a thickness of 12 mm. 8 drops each from 2 300ml blood collection bags
Attach the above leukocyte removal filter at the position of 00 mm,
Further, a 1-liter infusion bag was attached 800 mm below to form a recovery bag for storing the treated liquid, and a processing device was prepared in which the collection bag was connected with tubes having an inner diameter of 3 mm and an outer diameter of 5 mm. Two blood collection bags of this processing device, blood concentrated liquid with fresh CPD solution containing 64% hematocrit of an O-type healthy person (part of which plasma was removed by centrifugation)
200 ml each of which was stored at 4 ° C. for 1 day was put into the refrigerator at 4 ° C. by a free fall method using a drop, and immediately, leukocyte removal treatment was performed at room temperature at 10 ° C. one bag at a time.

【0039】次に、生理食塩水220mlを自然落下法に
より、この白血球除去フィルターに流し、フィルター内
の赤血球を回収した。その結果、この新鮮血液400ml
の処理時間は6分27秒であり、処理速度にして62ml
/分という高流速であった。また、白血球除去率は9
8.9%であり、赤血球の回収率は91%であった。
Next, 220 ml of physiological saline was flown through this leukocyte removal filter by the free fall method to collect red blood cells in the filter. As a result, 400 ml of this fresh blood
Processing time is 6 minutes 27 seconds, and the processing speed is 62 ml.
The flow rate was as high as / min. The leukocyte removal rate is 9
It was 8.9% and the recovery rate of red blood cells was 91%.

【0040】比較例4 直径3.8μmのポリエステル繊維から成る嵩密度0.
16g/cm3 の不織布を、直径が100mm、長さ6mmの
円柱状に切断し、有効内径90mm、厚さ10mmのカラム
中に固定した。300mlの採血バッグ2個からそれぞれ
落差800mmの位置に、上記の白血球除去フィルター装
置をつけ、さらに800mm下方に1リットルの輸液バッ
グをつけて、処理した血液を貯蔵する回収バッグとし、
その間をそれぞれ内径3mm、外径5mmのチューブで連結
した処理装置を作成した。この処理装置の採血バッグ2
個に、A型の健康人のヘマトクリット44%の新鮮CP
D液添加血液全血250mlずつを入れ、落差を利用した
自然落下法により、室温25℃で1バッグずつ順番に白
血球除去処理を行った。
Comparative Example 4 Bulk Density of 0.8 μm Made of Polyester Fiber
A 16 g / cm 3 non-woven fabric was cut into a column having a diameter of 100 mm and a length of 6 mm and fixed in a column having an effective inner diameter of 90 mm and a thickness of 10 mm. Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 300 ml blood collection bags, and attach a 1 liter infusion bag 800 mm below to make a collection bag for storing the treated blood.
A processing device was produced by connecting the spaces with tubes each having an inner diameter of 3 mm and an outer diameter of 5 mm. Blood collection bag 2 of this processing device
A CP of 44% of hematocrit of type A healthy person
250 ml of whole blood added with D liquid was put in each, and leukocyte removal treatment was carried out one bag at a time at a room temperature of 25 ° C. by a free fall method using a drop.

【0041】次に、生理食塩水80mlを自然落下法によ
り、この白血球除去フィルター装置に流し、フィルター
内の赤血球を回収した。その結果、この新鮮血液500
mlの処理時間は6分48秒であり、処理速度にして74
ml/分という高流速であった。しかし、白血球除去率は
75%と低かった。赤血球42率は94%であった。
Next, 80 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 500
The processing time of ml is 6 minutes 48 seconds, and the processing speed is 74
The flow rate was as high as ml / min. However, the leukocyte removal rate was low at 75%. The red blood cell 42 rate was 94%.

【0042】比較例5 直径が7.0μmのポリエステル繊維から成る嵩密度
0.16g/cm3 の不織布を、直径が100mm、長さ6
mmの円柱状に切断し、有効内径90mm、厚さ10mmのカ
ラム中に固定した。300mlの採血バッグ2個からそれ
ぞれ落差800mmの位置に、上記の白血球除去フィルタ
ー装置をつけ、さらに800mm下方に1リットルの輸液
バッグをつけて、処理した血液を貯蔵する回収バッグと
し、その間をそれぞれ内径3mm、外径5mmのチューブで
連結した処理装置を作成した。この処理装置の採血バッ
グ2個に、A型の健康人のヘマトクリット46%の新鮮
CPD液添加血液全血250mlずつを入れ、落差を利用
した自然落下法により、室温25℃にて1バッグずつ順
番に白血球除去処理を行った。
Comparative Example 5 A non-woven fabric having a bulk density of 0.16 g / cm 3 made of polyester fibers having a diameter of 7.0 μm was used, and the diameter was 100 mm and the length was 6
It was cut into a column of mm and fixed in a column having an effective inner diameter of 90 mm and a thickness of 10 mm. Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 300 ml blood collection bags, and further attach a 1 liter infusion bag 800 mm below to make a collection bag for storing the treated blood, and each of them has an inner diameter between them. A processing device connected by a tube having a diameter of 3 mm and an outer diameter of 5 mm was prepared. 250 ml of fresh blood with added CPD solution of 46% hematocrit of type A healthy person is put into two blood collection bags of this processing device, and one bag is placed at room temperature at 25 ° C one by one by the free fall method using the drop. The white blood cells were subjected to leukocyte removal treatment.

【0043】次に、生理食塩水80mlを自然落下法によ
り、この白血球除去フィルター装置に流し、フィルター
内の赤血球を回収した。その結果、この新鮮血液500
mlの処理時間は5分26秒であり、処理速度にして92
ml/分という高流速であった。しかし、白血球除去率は
58%と低かった。赤血球回収率は93%であった。
Next, 80 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 500
The processing time of ml is 5 minutes and 26 seconds, and the processing speed is 92
The flow rate was as high as ml / min. However, the leukocyte removal rate was as low as 58%. The red blood cell recovery was 93%.

【0044】比較例6 直径2.4μmのポリエステル繊維から成る嵩密度0.
6g/cm3 の不織布を、直径が100mm、長さ6mmの円
柱状に切断し、有効内径90mm、厚さ10mmのカラム中
に固定した。300mlの採血バッグ2個からそれぞれ落
差800mmの位置に、上記の白血球除去フィルター装置
をつけ、さらに800mm下方に1リットルの輸液バッグ
をつけて、処理した液を貯蔵する回収バッグとし、その
間をそれぞれ内径3mm、外径5mmのチューブで連結した
処理装置を作成した。この処理装置の採血バッグ2個
に、A型の健康人のヘマトクリット49%の新鮮CPD
液添加血液全血250mlずつを入れ、落差を利用した自
然落下法により、室温25℃で1バッグずつ順番に白血
球除去処理を行った。しかし、白血球除去フィルター装
置が詰まってしまい、血液は25mlしか得られなかっ
た。得られた血液だけについて分析したところ、白血球
除去率は100%であり、赤血球回収率は5%であっ
た。
Comparative Example 6 Bulk density of 0.4 μm consisting of polyester fibers having a diameter of 2.4 μm
A non-woven fabric of 6 g / cm 3 was cut into a column having a diameter of 100 mm and a length of 6 mm and fixed in a column having an effective inner diameter of 90 mm and a thickness of 10 mm. Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 300 ml blood collection bags, and further attach a 1 liter infusion bag 800 mm below to form a collection bag for storing the treated liquid, with the inside diameters between them. A processing device connected by a tube having a diameter of 3 mm and an outer diameter of 5 mm was prepared. Two blood collection bags of this processing device, fresh CPD of hematocrit 49% of type A healthy person
250 ml of whole blood added with liquid was put in each, and leukocyte removal treatment was carried out one bag at a time at room temperature of 25 ° C. by a free fall method using a drop. However, the leukocyte removal filter device was clogged and only 25 ml of blood was obtained. When only the obtained blood was analyzed, the leukocyte removal rate was 100% and the red blood cell recovery rate was 5%.

【0045】比較例7 直径が2.4μmのポリエステル繊維から成る嵩密度
0.05g/cm3 の不織布を、直径が100mm、長さ6
mmの円柱状に切断し、有効内径90mm、厚さ10mmのカ
ラム中に固定した。300mlの採血バッグ2個からそれ
ぞれ落差800mmの位置に、上記の白血球除去フィルタ
ー装置をつけ、さらに800mm下方に1リットルの輸液
バッグをつけて、処理した液を貯蔵する回収バッグと
し、その間をそれぞれ内径3mm、外径5mmのチューブで
連結した処理装置を作成した。この処理装置の採血バッ
グ2個に、A型の健康人のヘマトクリット46%の新鮮
CPD液添加血液全血250mlずつを入れ、落差を利用
した自然落下法により、室温25℃で1バッグずつ順番
に白血球除去処理を行った。
Comparative Example 7 A nonwoven fabric made of polyester fiber having a diameter of 2.4 μm and having a bulk density of 0.05 g / cm 3 was used, and the diameter was 100 mm and the length was 6 mm.
It was cut into a column of mm and fixed in a column having an effective inner diameter of 90 mm and a thickness of 10 mm. Attach the above leukocyte removal filter device at the position of 800 mm drop from each of the 300 ml blood collection bags, and further attach a 1 liter infusion bag 800 mm below to form a collection bag for storing the treated liquid, with the inside diameters between them. A processing device connected by a tube having a diameter of 3 mm and an outer diameter of 5 mm was prepared. 250 ml of fresh CPD solution-added whole blood of hematocrit 46% of type A healthy person is put into two blood collection bags of this processing device, and one bag is placed at a room temperature of 25 ° C one by one by a free fall method using a drop. Leukocyte removal treatment was performed.

【0046】次に、生理食塩水80mlを自然落下法によ
り、この白血球除去フィルター装置に流し、フィルター
内の赤血球を回収した。その結果、この新鮮血液500
mlの処理時間は3分24秒であり、処理速度にして14
7ml/分という高流速であった。しかし、白血球除去率
は63%と低かった。赤血球回収率は97%であった。
各実施例および比較例の結果をまとめて表1に示す。
Next, 80 ml of physiological saline was flown through this leukocyte removal filter device by the free fall method to collect red blood cells in the filter. As a result, this fresh blood 500
The processing time of ml is 3 minutes and 24 seconds, and the processing speed is 14
The flow rate was as high as 7 ml / min. However, the leukocyte removal rate was low at 63%. The red blood cell recovery was 97%.
The results of each Example and Comparative Example are summarized in Table 1.

【0047】[0047]

【表1】 [Table 1]

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の白血球除去フィルターによるフィルタ
ー装置の一実施態様を示す正面図である。
FIG. 1 is a front view showing an embodiment of a filter device using a leukocyte removal filter of the present invention.

【図2】本発明の白血球除去フィルターによるフィルタ
ー装置の一実施態様を示す縦断側面図である。
FIG. 2 is a vertical sectional side view showing an embodiment of a filter device using the leukocyte removal filter of the present invention.

【図3】別の実施態様を示す正面図である。FIG. 3 is a front view showing another embodiment.

【図4】別の実施態様を示す縦断側面図である。FIG. 4 is a vertical sectional side view showing another embodiment.

【図5】本発明の白血球除去フィルターによるフィルタ
ー装置の使用態様を示す説明図である。
FIG. 5 is an explanatory view showing a mode of use of the filter device using the leukocyte removal filter of the present invention.

【符号の説明】[Explanation of symbols]

1 フィルター装置本体 2,2’ 丸盆状枠体 3 リング部材 4,4’ 突状 5,5’ メッシュ状支持材 6 フィルター 7 血液流入管 8 血液流出管 9,9’ パッキング 10,10’ 丸盆状枠体 11,11’ メッシュ状支持材 12 フィルター 13 血液流入管 14 血液流出管 15,15’ パッキング 16 採血バッグ 17 回路 18 フィルター装置 19 回路 20 回収バッグ 21 生理食塩水バッグ 22 回路 23 回収バッグ 24 調整バルブ 1 Filter device body 2, 2'Round tray frame 3 Ring member 4, 4 'Projection 5, 5' Mesh support 6 Filter 7 Blood inflow pipe 8 Blood outflow pipe 9, 9 'Packing 10, 10' Round Tray frame 11, 11 'Mesh-like support material 12 Filter 13 Blood inflow tube 14 Blood outflow tube 15, 15' Packing 16 Blood collection bag 17 Circuit 18 Filter device 19 Circuit 20 Recovery bag 21 Saline solution bag 22 Circuit 23 Recovery bag 24 Adjustment valve

Claims (1)

【特許請求の範囲】[Claims] 繊維の直径が3μm未満で嵩密度が0.15g/cm3
超え0.50g/cm3以下の不織布からなるフィルター
の一方の面に多量の血球浮遊液を供給し、他方の面へ通
過させることにより前記血球浮遊液中の白血球を実質的
に全て前記不織布に捕捉させることを特徴とする血球浮
遊液から白血球を選択的に除去する方法。
The diameter of the fibers supplying a large amount of the blood cell suspension to one side of the filter the bulk density is from beyond 0.50 g / cm 3 or less of the nonwoven fabric 0.15 g / cm 3 less than 3 [mu] m, to pass to the other side Thus, substantially all the white blood cells in the blood cell suspension are captured by the nonwoven fabric, and the method for selectively removing white blood cells from the blood cell suspension.
JP3135364A 1984-03-15 1991-05-13 How to selectively remove white blood cells Expired - Lifetime JPH0651063B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP59048173A JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter
JP3135364A JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59048173A JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter
JP3135364A JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59048173A Division JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter

Publications (2)

Publication Number Publication Date
JPH0663131A true JPH0663131A (en) 1994-03-08
JPH0651063B2 JPH0651063B2 (en) 1994-07-06

Family

ID=26388401

Family Applications (2)

Application Number Title Priority Date Filing Date
JP59048173A Granted JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter
JP3135364A Expired - Lifetime JPH0651063B2 (en) 1984-03-15 1991-05-13 How to selectively remove white blood cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP59048173A Granted JPS60193468A (en) 1984-03-15 1984-03-15 Leucocyte removal filter

Country Status (1)

Country Link
JP (2) JPS60193468A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048464A (en) * 1995-12-26 2000-04-11 Asahi Medical Co., Ltd. Filter medium for leukocyte removal, method of making, and method of using thereof
JP2009018177A (en) * 2001-10-16 2009-01-29 Asahi Kasei Kuraray Medical Co Ltd Material for selectively removing virus and leukocyte and use thereof
JP2009072609A (en) * 1999-04-20 2009-04-09 Fenwal Inc Filter assembly having flexible housing

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785459T2 (en) * 1986-10-06 1993-08-19 Terumo Corp DISCONNECTING DEVICE OF A BLOOD COMPONENT.
JPH0614968B2 (en) * 1987-06-15 1994-03-02 テルモ株式会社 Leukocyte capture and separation device
JPH0720539B2 (en) * 1988-03-03 1995-03-08 テルモ株式会社 White blood cell separator
JPH0659304B2 (en) * 1988-06-23 1994-08-10 旭メディカル株式会社 Blood component separation method
JPH0659305B2 (en) * 1988-06-23 1994-08-10 旭メディカル株式会社 Blood component separation method
JPH03188872A (en) * 1989-12-20 1991-08-16 Taiichiro Iwakura Method for deactivating aids virus
ATE197547T1 (en) * 1991-08-22 2000-12-15 Asahi Medical Co FILTER MEDIUM FOR SELECTIVE REMOVAL OF LEUKOCYTES AND CORRESPONDING DEVICE
TW434036B (en) * 1998-05-13 2001-05-16 Asahi Medical Co Filter device and method for processing blood
EP1230940B1 (en) 1999-11-01 2007-06-13 Asahikasei Medical Co., Ltd. Filter for selectively removing leukocytes
JP2002113097A (en) * 2000-05-23 2002-04-16 Toray Ind Inc Adsorbent and in vitro circulation column
JP4505950B2 (en) * 2000-06-06 2010-07-21 東レ株式会社 Adsorbent and extracorporeal circulation column
WO2005120600A1 (en) 2004-06-09 2005-12-22 Asahi Kasei Medical Co., Ltd. Method for removing leukocyte and filter for use therein
US8496833B2 (en) 2005-01-06 2013-07-30 Asahi Kasei Medical Co., Ltd. Leukocyte removal method
US8584869B2 (en) 2005-03-31 2013-11-19 Toray Industries, Inc. Absorbent and column for extracorporeal circulation
EP2058018A4 (en) * 2006-08-31 2014-01-22 Toray Industries Adsorption carrier containing composite fiber
WO2008038785A1 (en) 2006-09-29 2008-04-03 Toray Industries, Inc. Cell-adsorbing column
CA2704567C (en) 2007-12-27 2016-01-12 Toray Industries, Inc. Fiber construct for treating biological components
JP5281655B2 (en) * 2008-12-03 2013-09-04 テルモ株式会社 Blood bag system and blood processing method
AU2011321457B2 (en) 2010-10-27 2014-06-05 Toray Industries, Inc. Carrier for blood component adsorption and blood component adsorption column
JP2012120458A (en) * 2010-12-06 2012-06-28 Kaneka Corp Cell separator
EP3081241A4 (en) 2013-12-13 2016-12-21 Asahi Kasei Medical Co Ltd Leukocyte removal filter material and leukocyte removal method
US10814051B2 (en) 2015-06-17 2020-10-27 Asahi Kasei Medical Co., Ltd. Filter element for blood processing filter and blood processing filter
JP6210651B2 (en) * 2016-01-18 2017-10-11 フォースエンジニアリング株式会社 Medical filter device
US20200215253A1 (en) 2017-09-08 2020-07-09 Toray Industries, Inc. Immunosuppressive leukocyte adsorption material and adsorption column
WO2020183951A1 (en) * 2019-03-12 2020-09-17 テルモ株式会社 Filtration device
WO2023074729A1 (en) 2021-11-01 2023-05-04 東レ株式会社 Cell adsorption material and cell adsorption column

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5854125B2 (en) * 1978-03-06 1983-12-02 旭化成株式会社 Leukocyte separation filter and leukocyte separation method
JPS5521535A (en) * 1978-07-31 1980-02-15 Nippon Steel Corp Producing method of highly tough and tensile low alloy steel
US4283289A (en) * 1979-08-22 1981-08-11 Baxter Travenol Laboratories, Inc. Blood filter for leukocytes
JPS603367B2 (en) * 1979-10-09 1985-01-28 旭化成株式会社 Leukocyte separation method and leukocyte separation material
JPS6012578Y2 (en) * 1980-07-08 1985-04-23 三菱レイヨン株式会社 Fiber entanglement separation material

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048464A (en) * 1995-12-26 2000-04-11 Asahi Medical Co., Ltd. Filter medium for leukocyte removal, method of making, and method of using thereof
JP2009072609A (en) * 1999-04-20 2009-04-09 Fenwal Inc Filter assembly having flexible housing
JP2009018177A (en) * 2001-10-16 2009-01-29 Asahi Kasei Kuraray Medical Co Ltd Material for selectively removing virus and leukocyte and use thereof

Also Published As

Publication number Publication date
JPH0651063B2 (en) 1994-07-06
JPS60193468A (en) 1985-10-01
JPH0213587B2 (en) 1990-04-04

Similar Documents

Publication Publication Date Title
JPH0663131A (en) Method for selectively removing leucocyte
US4701267A (en) Method for removing leukocytes
JP6208186B2 (en) Blood component separation system, separation material
US4330410A (en) Separation of leukocytes from leukocyte-containing suspension by filtration
JPH03173825A (en) Filter for purifying blood platelet
US6177019B1 (en) Method and apparatus for removing tumor cells from tumor cell-contaminated stem cell products
JPH0213588B2 (en)
US6964646B1 (en) Device and method for autologous blood transfusion
KR910006820B1 (en) Leucocyte seperating filter
JPH0534337A (en) Filter for separating leucocyte
JPH0659304B2 (en) Blood component separation method
JP2888590B2 (en) Equipment for plasma and packed red blood cell collection
JPH04329965A (en) Selective removal method of leukocyte
JPH08104643A (en) Method for removing erythrocyte
JP2918595B2 (en) White blood cell separator
JP2559615B2 (en) Leukocyte capture filter for concentrated red blood cells
JPS5854130B2 (en) Leukocyte separation method
JPS5854125B2 (en) Leukocyte separation filter and leukocyte separation method
JP2000334034A (en) Blood component separation method
JPH01320065A (en) Blood component separating system
JPH0566152B2 (en)
JPS5854126B2 (en) Leukocyte separation material
JPS5936886B2 (en) How to isolate white blood cells
JP3101356B2 (en) Leukocyte removal filter
JP3157519B2 (en) Blood component separation system

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term